Resultats de la cerca - Sanson, M.

Cases Illustrative of the Different Methods of Operating for the Stone per Dupuytren, M., Sanson, M.

Obtenir text complet Obtenir text complet

Glioblastoma targeted therapy: updated approaches from recent biological insights per Touat, M., Idbaih, A., Sanson, M., Ligon, K. L.

Obtenir text complet Obtenir text complet Obtenir text complet

Dramatic improvement in non-AIDS related progressive multifocal leucoencephalopathy per Aure, K, Behin, A, Louillet, F, Lafitte, C, Sanson, M, Vernant, J

Obtenir text complet Obtenir text complet Obtenir text complet

PL02.4.A Chromosome 1p19q codeletion frequency, but not survival, varies according to the IDH mutation subtypes: analysis of 1050 IDH-mutated diffuse gliomas per Picca, A, Berzero, G, Di Stefano, A, Trabelsi, N, Bielle, F, Sanson, M

Obtenir text complet Obtenir text complet

Parental origin of chromosome 22 alleles lost in meningioma. per Sanson, M, Delattre, O, Couturier, J, Philippon, J, Cophignon, J, Derome, P, Rouleau, G A, Thomas, G

Obtenir text complet Obtenir text complet

P04.14 IDH1 MUTATION IN LOW-GRADE GLIOMAS RELATED TO EPILEPSY AS INITIAL SYMPTOM per Duran-Peña, A., Mokhtari, K., Marie, Y., Alentorn, A., Delattre, J., Idbaih, A., Sanson, M., Vecht, C.

Obtenir text complet Obtenir text complet

O8.08 CIC MUTATION IS A POOR PROGNOSIS FACTOR IN 1P19Q CODELETED GLIOMAS, ASSOCIATED TO AN UP-REGULATION OF PROLIFERATION PATHWAYS per Gleize, V., Alentorn, A., Connen de Kérillis, L., Labussière, M., Mangesius, S., Ducray, F., Mokhtari, K., Villa, C., Sanson, M.

Obtenir text complet Obtenir text complet

OS6.6 CEVOREM Trial: Combination of EVerolimus and Octreotide in REsistant MeningiomasPresentation and Preliminary results per Graillon, T., Peyre, M., Kalamarides, M., Sanson, M., Barrié, M., Campello, C., Tabouret, E., Roche, P., Dufour, H., Chinot, O.

Obtenir text complet Obtenir text complet

P04.10 IDH-wildtype low grade gliomas: overall survival and prognostic indicators per Berzero, G, Di Stefano, A, Ronchi, S, Villa, C, Marie, Y, Hoang-Xuan, K, Delattre, J, Mokhtari, K, Sanson, M

Obtenir text complet Obtenir text complet

P08.63 Dose optimization of MK-8628 (OTX015), a small molecule inhibitor of bromodomain and extra-terminal (BET) proteins, in patients with recurrent glioblastoma per Hottinger, A. F., Sanson, M., Moyal, E., Delord, J., Rezai, K., Leung, A., Perez, S., Bekradda, M., Lachaux, N., Chinot, O.

Obtenir text complet Obtenir text complet

P05.02 KIAA1549:BRAF FUSION GENE IN PEDIATRIC BRAIN TUMORS OF VARIOUS HISTOGENESIS per Baldi, C., Antonelli, M., Badiali, M., Buttarelli, F.R., Moi, L., Nozza, P., Arcella, A., Massimino, M., Sanson, M., Giangaspero, F.

Obtenir text complet Obtenir text complet

O6.08 COMBINED ANALYSIS OF TERT, EGFR AND IDH STATUS DEFINE DISTINCT PROGNOSTIC CLASSES OF GLIOBLASTOMA per Labussiere, M., Boisselier, B., Mokhtari, K., Di Stefano, A., Rahimian, A., Saulnier, O., Paterra, R., Finocchiaro, G., Marie, Y., Sanson, M.

Obtenir text complet Obtenir text complet

P01.148 Intra-tumor heterogeneity analysis of low-grade gliomas. A POLA Network study per Alentorn, A, Labreche, K, Dehais, C, Carpentier, C, Ducray, F, Mokhtari, K, Figarella-Branger, D, Sanson, M, Delattre, J, Idbaih, A

Obtenir text complet Obtenir text complet

O6.07 FGFR3-TACC3 AND EGFR-SEPT14 GENE FUSIONS IN ADULT GLIOMAS per Di Stefano, A. L., Labussiere, M., Frattini, V., Fucci, A., Boisselier, B., Schmitt, Y., Mokhtari, K., Lasorella, A., Iavarone, A., Sanson, M.

Obtenir text complet Obtenir text complet

P06.18 DNA methylation distance score in lower-grade gliomas has prognostic value: a POLA network study per Alentorn, A., Kamoun, A., Ducray, F., Dehais, C., Mokhtari, K., Uro-Coste, E., Figarella-Branger, D., Delattre, J., Idbaih, A., Sanson, M.

Obtenir text complet Obtenir text complet

P07.15 Diagnostic value of 2-hydroxyglutarate detection by 1H MR spectroscopy in patients with glioma and correlations with tumor phenotype and tissue dosage per Di Stefano, A. L., Branzoli, F., Ottolenghi, C., Capelle, L., Mokhtari, K., Villa, C. M., Giry, M., Marjanska, M., Lehericy, S., Sanson, M.

Obtenir text complet Obtenir text complet

P09.14 Clonal and subclonal evolution of 1p/19q co-deleted oligodendrogliomas per Alentorn, A., Daniau, M., Royer-Perron, L., Labreche, K., Duran-Pena, A., Marie, Y., Hoang-Xuan, K., Sanson, M., Delattre, J., Idbaih, A.

Obtenir text complet Obtenir text complet

EH1.1 Results of the interim analysis of the EORTC randomized phase III CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p/19q co-deletion, an int... per van den Bent, M. J., Erridge, S., Vogelbaum, M., Nowak, A., Sanson, M., Brandes, A. A., Golfinopoulos, V., Gorlia, T., Kros, J. M., Baumert, B. G.

Obtenir text complet Obtenir text complet

P01.12 Stability of actionable mutations in primary and recurrent glioblastomas per French, P. J., Taphoorn, M., Weyerbrock, A., Sanson, M., Hoeben, A., Lukavoca, S., Lombardi, G., Hanse, M., Watts, C., Golfinopoulos, V., McDermott, U., Robe, P.

Obtenir text complet Obtenir text complet

OS8.5 How to assess meningioma therapy activity: The CEVOREM independent central review experience per GRAILLON, T, Colin, T, Peyrière, H, Peyre, M, Tabouret, E, Campello, C, Idbaih, A, Boucekine, M, Figarella-Branger, D, Kalamarides, M, Dufour, H, Sanson, M, Chinot, O

Obtenir text complet Obtenir text complet